News & Media

What motivates you to do your best work? Have you had a female mentor in STEM? Read up on roundtable reflections in recognition of the International Day of Women and Girls in Science, Feb 11, 2022.

On World Cancer Day 2022, we look to progress and challenges in areas critical to the development of extracellular vesicle-based biomarkers for early cancer detection.

The Tasmanian devil species is threatened by transmissible facial tumours. Do extracellular vesicles hold the key to better conservation strategies?

How tunable resistive pulse sensing (TRPS) enables precise EV measurements.

Why the signal-to-noise ratio is important for EV-based diagnostics.

10 recent qEV-enabled publications across diverse areas of EV research.

5 recent virus-related papers featuring qEV isolation or TRPS.

What does it take to make an EV biomarker successful?

The strong case for extracellular vesicle-based biomarkers.

FAQs about the qEV1

Gen 2 qEV columns with novel resin deliver a higher level of EV purity.

A wrap-up of 5 recent publications featuring tunable resistive pulse sensing.

When EVs meet Alzheimer’s disease – exploring this fascinating area of research in light of World Alzheimer’s Month 2021.

Notes from a conversation with Assistant Professor Stephanie Jung, University Hospital of Bonn (Germany), who separated Hepatitis B and antibodies from EVs to enable functional EV-virology studies.

After an encounter with a not-for-profit organisation raising scientific literacy in NZ, Izon Science would like to share their story in the hope of garnering further support for the House of Science.

Four reasons why storage conditions matter to the world of extracellular vesicle research.

An optimised, clinically relevant method for proteomic analysis of plasma EVs, featuring qEV isolation, is now documented in Cell Reports Methods.

Izon Science has recently executed a Product Development Agreement with BCAL Diagnostics.

On World Hepatitis Day 2021, we explore how researchers are pursuing extracellular vesicles as a way to improve outcomes for people with hepatitis.

A summary of work by Caputo et al (2021) who conducted a side-by-side comparison of ten analytical techniques for the characterisation of nanoplastics and microplastics.

A summary of the first ISEV 2021 plenary session by Andrew Hill, La Trobe University. This presentation explored EVs and their role in neurogenerative diseases, with a particular focus on prion diseases.

Together, the qEV Concentration Kit and qEV RNA Extraction Kit provide streamlined and standardised solutions for isolating and concentrating EVs and extracting EV-RNA for downstream analysis.

To help you select a suitable method for your research, we identified three key questions that get to the core of what’s important for characterising nanoparticles.

In brief: a summary of work by Vogel et al. (2021), who compared six methods for nanoparticle analysis, and assessed their capabilities using synthetic and biological nanovesicles of varying complexity.

To strengthen the analysis of nanoparticle size, concentration, and charge, Izon Science has released the Exoid – a new-generation Tunable Resistive Pulse Sensing (TRPS) technology.

Dr Gwennan André-Grégoire is a researcher affiliated with the Integrated Center for Cancerology (ICO), working in the Cancerology and Immunology Research Center Nantes-Angers (CRCINA), a public laboratory. Her current position in the Signaling in Oncogenesis, Angiogenesis and Permeability (SOAP) group—led by Dr Julie Gavard—follows a PhD and postdoctoral position in Paris, and previous postdoctoral position in the SOAP group.

A robust antibody titer is essential in preventing lung lesions associated with Actinobacillus pleuropneumoniae (App) – as discussed in this interview with Dr. Fabio Antenucci, University of Copenhagen.

If you are yet to join the high-definition revolution, we recommend you read these three studies that harness the accuracy of TRPS measurements.

Exploring the changing landscape of cannabis legislation in the US: implications for the biopharma sector.

Two researchers from the Paris Cardiovascular Research Centre, Dr. Pierre-Michaël Coly and Stephane Mazlan, discuss how they are decoding the role of EVs in cardiovascular health.